Department of Chemistry, Texas A&M University, P.O. Box 30012, College Station, Texas 77842-3012, USA.
J Am Chem Soc. 2012 Feb 15;134(6):3084-94. doi: 10.1021/ja209163w. Epub 2012 Feb 2.
The ZnCl(2)-mediated tandem Mukaiyama aldol lactonization (TMAL) reaction of aldehydes and thiopyridyl ketene acetals provides a versatile, highly diastereoselective approach to trans-1,2-disubstituted β-lactones. Mechanistic and theoretical studies described herein demonstrate that both the efficiency of this process and the high diastereoselectivity are highly dependent upon the type of ketene acetal employed but independent of ketene acetal geometry. Significantly, we propose a novel and distinct mechanistic pathway for the ZnCl(2)-mediated TMAL process versus other Mukaiyama aldol reactions based on our experimental evidence to date and further supported by calculations (B3LYP/BSI). Contrary to the commonly invoked mechanistic extremes of [2+2] cycloaddition and aldol lactonization mechanisms, investigations of the TMAL process suggest a concerted but asynchronous transition state between aldehydes and thiopyridyl ketene acetals. These calculations support a boat-like transition state that differs from commonly invoked Mukaiyama "open" or Zimmerman-Traxler "chair-like" transition-state models. Furthermore, experimental studies support the beneficial effect of pre-coordination between ZnCl(2) and thiopyridyl ketene acetals prior to aldehyde addition for optimal reaction rates. Our previously proposed, silylated β-lactone intermediate that led to successful TMAL-based cascade sequences is also supported by the described calculations and ancillary experiments. These findings suggested that a similar TMAL process leading to β-lactones would be possible with an oxopyridyl ketene acetal, and this was confirmed experimentally, leading to a novel TMAL process that proceeds with efficiency comparable to that of the thiopyridyl system.
ZnCl2 介导的串联 Mukaiyama 缩醛化内酯化(TMAL)反应醛和噻吡啶基烯酮缩醛提供了一种通用的、高度非对映选择性的方法,用于合成反式 1,2-二取代的β-内酰胺。本文描述的机理和理论研究表明,该过程的效率和高非对映选择性高度依赖于所使用的烯酮缩醛的类型,但与烯酮缩醛的几何形状无关。重要的是,我们根据目前的实验证据并进一步通过计算(B3LYP/BSI)支持,提出了一种与其他 Mukaiyama 缩醛反应不同的 ZnCl2 介导的 TMAL 过程的新颖而独特的机理途径。与通常提出的[2+2]环加成和缩醛内酯化机理的极端机理相比,对 TMAL 过程的研究表明,醛和噻吡啶基烯酮缩醛之间存在协同但异步的过渡态。这些计算支持了一种船形过渡态,与通常提出的 Mukaiyama“开”或 Zimmerman-Traxler“椅形”过渡态模型不同。此外,实验研究支持 ZnCl2 与噻吡啶基烯酮缩醛在醛加成之前预先配位,以获得最佳反应速率的有益效果。我们之前提出的、成功进行 TMAL 基级联序列的硅化β-内酰胺中间体也得到了描述的计算和辅助实验的支持。这些发现表明,类似的 TMAL 过程也可能导致β-内酰胺的形成,如果使用氧代吡啶基烯酮缩醛,则可以得到证实,从而形成一种新的 TMAL 过程,其效率与噻吡啶基体系相当。